Hepatitis A, B and C Reports
- Hepatitis A, B and C Annual Report, 2023 (PDF)
- 2023 Appendices (PDF)
- Hepatitis A, B and C Annual Report, 2022 (PDF)
- 2022 Appendices (PDF)
- Hepatitis A, B and C Annual Report, 2021 (PDF)
- 2021 Appendices (PDF)
- Hepatitis A, B and C Annual Report, 2020 (PDF)
- 2020 Appendices (PDF)
- Hepatitis A, B and C Annual Report, 2019 (PDF)
- 2019 Appendices (PDF)
- Hepatitis A, B and C Annual Report, 2018 (PDF)
- 2018 Appendices (PDF)
- Hepatitis A, B and C Annual Report, 2017 (PDF)
- 2017 Appendices (PDF)
- Hepatitis B and C Annual Report, 2015 (PDF)
- Hepatitis B and C Annual Report, 2014 (PDF)
- Hepatitis B and C Surveillance Report, 2013 (PDF)
- Hepatitis A, B and C Surveillance Report, 2008 and 2009 (PDF)
- Hepatitis A, B and C Surveillance Report, 2006 and 2007 (PDF)
- Hepatitis A, B and C Surveillance Report, 2005 (PDF)
These reports feature hepatitis A, B and C surveillance data and summaries of viral hepatitis programs and services delivered in NYC for the calendar year, or most recent available data.
Appendices describe newly reported cases of hepatitis A, B, and C; people with hepatitis A, B, and C; and deaths among people with hepatitis B and C for NYC overall and by sex, gender, race and ethnicity, age, borough, transmission category, and neighborhood.
Special Reports
Hepatitis B Birth Dose Vaccine Coverage
A universal birth dose of hepatitis B vaccine helps to prevent hepatitis B transmission to infants. The Hepatitis B Vaccine Birth Dose Coverage Annual Report uses Health Department data to show the performance of delivery facilities. The goal of these reports is to achieve a hepatitis B birth dose coverage rate of 90% or greater.
The report includes comparison of NYC delivery facilities and number and percentage of infants who received hepatitis B vaccine within three days of birth.2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012
Hepatitis C Hospital Dashboards
The Hepatitis C Hospital Dashboards use Health Department surveillance data to show the performance of hospitals and health care facilities that provide hepatitis C care to NYC residents. The goal of these dashboards is to improve hepatitis C care and treatment in NYC.
The dashboards include three indicators: antibody testing, RNA confirmation testing, and treatment initiation rates. They can be used to monitor care, measure outcomes, compare rates across facilities, and advocate for institutional changes.
If you have questions about the dashboards, email hep@health.nyc.gov.